TGF-β1 and TGF-β2 mostly contribute to cancer progression by acting in both tumor cells and stromal cells [6], [7], and a loss of sensitivity to growth inhibition by TGF-β is thought to occur in most cancer cells. This evidence concerns the gene TGFB2 and neoplasm.